Plasmapheresis for lowering the risks of placenta-associated complications in antiphospholipid syndrome
Aim: to study plasmapheresis (PP) effect on antiphospholipid syndrome (APS) treatment during preconception preparation and pregnancy.Materials and Methods. A single-center, prospective, randomized, uncontrolled study was conducted. A total of 137 women aged 22 to 32 years diagnosed with APS-related...
Saved in:
Main Authors: | N. F. Kuneshko, V. V. Kim, E. M. Lyadnova, A. R. Metkina, M. N. Velieva, A. V. Lazarchuk, V. O. Bitsadze, M. V. Tretyakova, D. V. Blinov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2025-03-01
|
Series: | Акушерство, гинекология и репродукция |
Subjects: | |
Online Access: | https://www.gynecology.su/jour/article/view/2346 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiphospholipid antibodies as a potential factor of tumor progression
by: Z. D. Aslanova, et al.
Published: (2024-03-01) -
Detection frequency and duration of circulating antiphospholipid syndrome markers in patients with verified COVID-19
by: Yu. V. Mikhailova, et al.
Published: (2024-05-01) -
Autoantibodies and SARS-CoV-2 infection: A case report
by: T. I. Kalenchic, et al.
Published: (2022-07-01) -
Detection of antibodies associated with anti-phospholipid syndrome in patients with syphilis
by: N. K. Levchik, et al.
Published: (2023-04-01) -
Extra criterial antiphospholipid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data)
by: F. A. Cheldieva, et al.
Published: (2021-10-01)